Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAzimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial.AuthorsLombardi, Federico; Borggrefe, Martin; Ruzyllo, Witold; Lüderitz, BerndtAbstractAims Treatment of atrial fibrillation remains a major clinical challenge owing to the limited efficacy and safety of anti-arrhythmic drugs, particularly in patients with structural heart disease.PublicationEuropean Heart Journal, 2006, Vol 27, Issue 18, p2224ISSN0195-668XPublication typeArticleDOI10.1093/eurheartj/ehl209